Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Reason Magazine (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Defending the Court of International Trade Ruling Against Trump's Tariffs—A Reply to Jack Goldsmith

% of readers think this story is Fact. Add your two cents.



President Donald Trump holding a chart of
(Illustration: Eddie Marshall | Tupungato | Dreamstime.com | Chris Kleponis | CNP | picture alliance | Consolidated News Photos | Newscom)

Many prominent legal scholars and former government officials across the political spectrum have supported the lawsuit challenging Trump’s “Liberation Day” tariffs brought by the Liberty Justice Center and myself, and backed the recent US Court of International Trade decision in our favor. But the ruling does have its critics, and one of the most prominent is Harvard law Prof. Jack Goldsmith. He doesn’t quite conclude the ruling is wrong. But he clearly has serious reservations about it, outlined in a notable article on the Executive Functions substack, where he also criticizes the recent US District Court of DC  (DDC) ruling against the tariffs. In this post, I explain why those reservations are generally misplaced.

As the CIT opinion emphasized, the key factor behind the decision was the “unbounded” nature of the tariff authority claimed by Trump: “The question in the two cases before the court is whether the International Emergency Economic Powers Act of 1977 (“IEEPA”) delegates….  to the President…. authority to impose unlimited tariffs on goods from nearly every country in the world.” The CIT ruled IEEPA did not grant such limitless power, and that it would be an unconstitutional delegation of legislative power if it did.

Goldsmith contends “the administration did not claim an unbounded or limitless power” because “Trump’s tariffs complied with IEEPA’s substantive and procedural requirements.” He notes that Trump declared a “national emergency” with respect to trade deficits and further claimed the deficits are an “unusual and extraordinary threat” to the US economy and national security, thus supposedly meeting IEEPA’s requirements.

But Goldsmith overlooks the fact that the administration consistently maintained that the president has absolute, unreviewable discretion to determine qualifies as a “national emergency” and an “unusual and extraordinary threat.” And if trade deficits—which are completely normal and not a threat at all—qualify as an “unusual and extraordinary threat,” so can virtually anything. This is undeniably a claim to unlimited tariff authority. And the CIT rightly concluded as much.

As CIT Judge Jane Restani put it in oral argument, the administration’s position would allow the president to impose tariffs for any “crazy” reason, such as a “peanut butter shortage.” Indeed, the hypothetical peanut shortage tariff would be less abusive and ridiculous than Trump’s trade-deficit rationale. Peanut butter shortages are at least somewhat unusual, and would be a genuine problem, whereas trade deficits are neither.

The CIT also rightly concluded that IEEPA doesn’t leave determination of what tariffs to impose entirely up to the president: “IEEPA’s provisions… impose meaningful limits on any such authority it confers.” Such boundless discretion would render the words “unusual and extraordinary threat” superfluous (thereby violating a basic rule of statutory interpretation), and also create an unconstitutional delegation of “unbounded tariff authority to the President.”

Goldsmith also criticizes the CIT and DDC’s reliance on the “major questions” doctrine,  which requires Congress to “speak clearly” when authorizing the executive to make “decisions of vast economic and political significance.” Trump’s gargantuan IEEPA tariffs—starting the biggest trade war since the Great Depression and imposing some 1.4 to 2.2 trillion dollars in new taxes on Americans—raise a major question, if anything does. And the fact that no previous president has used IEEPA to impose any tariffs at all satisfy the additional criterion that MQD scrutiny is stronger when an assertion of power is unprecedented.

Goldsmith notes that a 1975 United States Court of Customs and Patent Appeals (CCPA) ruling in the Yoshida case upheld the Richard Nixon’s imposition of tariffs under the Trading with the Enemy Act (TWEA), the predecessor statute to Yoshida. But, as the CIT ruling explains at length, Yoshida did not rule that TWEA authorizes unlimited tariff authority, and indeed emphasized that such unlimited delegation would be unconstitutional. Moreover, in enacting IEEPA, Congress sought to limit previous presidential emergency powers, not perpetuate them. As a House of Representatives report leading to the enactment of IEEPA put it, the legislation is based on “a recognition that emergencies are by their nature rare and brief, and are not to be equated with normal ongoing problems.” Using IEEPA emergency powers to address “normal ongoing problems” is precisely what Trump is trying to do here.

Goldsmith also raises (without endorsing) the possibility that MQD does not apply to policies adopted by the president, as opposed to subordinate executive branch officials. I responded to that argument in detail here.

While not addessed in our case, a similar lawsuit filed by 12 states led by Oregon and decided in the same CIT ruling, also challenged Trump’s fentanyl-related IEEPA tariffs against Canada, Mexico, and China. The CIT ruled that those tariffs were not meaningfully “deal with” any “unusual and extraordinary threat” created by fentanyl smuggling. Trump argued the tariffs address the threat by creating “leverage” against the three countries, which was not a direct enough link, according to the court. Goldsmith contends that an indirect link is enough. But if creating potential leverage against some government —including one that isn’t even causing the threat—is enough of a connection than we have a backdoor to unlimited power. Virtually any tariff can potentially be used as leverage against some government to try to get them to do something that might potentially help curb a threat.

The amount of fentanyl entering the US from Canada is negligible, and most of that from Mexico is brought in by US citizens (whom the Mexican government cannot and should not prevent from returning home). If that is enough of a linkage to an  “unusual and extraordinary threat” to justify the imposition of massive tariffs under IEEPA, than anything is. Thus, CIT was right to reject Trump’s fentanyl tariffs, as well as the Liberation Day ones.

Goldsmith also criticizes the DDC decision, which unlike the CIT (which did not address this issue), ruled that IEEPA doesn’t authorize the imposition of tariffs at all. IEEPA nowhere even uses the word “tariff” or any synonym. Instead, it authorizes the president to “regulate . . . importation . . . of . . . any property in which any foreign country or a national thereof has any interest.” DDC Judge Rudolph Contreras rightly concluded that regulation and taxation are distinct powers, and thus the former does not include the latter. If the power to “regulate” includes an unlimited power to impose tariffs, then the Constitution’s grant to Congress of the power to “lay and collect Taxes, Duties, Imposts and Excises” would be superfluous, since Congress also has the authority to “regulate Commerce with foreign Nations.” At the very least, the power to “regulate” cannot create an unlimited power to impose tariffs. Judge Contreras’ opinion includes a detailed discussion of the distinction between the two powers that Goldsmith largely fails to address.

I do agree with Goldsmith that the major questions doctrine likely to be an important issue as these cases proceed on appeal. But appellate courts also have plenty of other reasons to affirm the CIT and DDC rulings against Trump’s tariffs.

The post Defending the Court of International Trade Ruling Against Trump’s Tariffs—A Reply to Jack Goldsmith appeared first on Reason.com.


Source: https://reason.com/volokh/2025/06/08/defending-the-court-of-international-trade-ruling-against-trumps-tariffs-a-reply-to-jack-goldsmith/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.